The Role of Psychogenic Factors in the Etiopathogenesis of Autoimmune Disorders in the Oral Cavity
Abstract
:Introduction
Discussions
Conclusions
Compliance with ethical standards
Conflicts of Interest disclosure
References
- Sharif, K.; Watad, A.; Bragazzi, N.L.; Lichtbroun, M.; Amital, H.; Shoenfeld, Y. Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmun Rev. 2018, 17, 53–72. [Google Scholar] [CrossRef] [PubMed]
- Ilchmann-Diounou H, Menard S. Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview. Front Immunol. 2020, 11, 1823. [Google Scholar] [CrossRef] [PubMed]
- Choe, J.Y.; Nair, M.; Basha, R.; Kim, B.J.; Jones, H.P. Defining Early Life Stress as a Precursor for Autoimmune Disease. Crit Rev Immunol. 2019, 39, 329–342. [Google Scholar] [CrossRef]
- Maté, G. When the Body Says No: The Cost of Hidden Stress; Vintage: Canada, 2004; 320p. [Google Scholar]
- Zucoloto, M.L.; Shibakura, M.E.W.; Pavanin, J.V.; et al. Severity of oral lichen planus and oral lichenoid lesions is associated with anxiety. Clin Oral Investig. 2019, 23, 4441–4448. [Google Scholar] [CrossRef]
- Sajewicz-Radtke, U.; Radtke, B.M.; Jurek, P.; et al. Psychological Functioning of Women Diagnosed with Lichen Planus and Other Diseases of the Oral Cavity-Explorative Study. Healthcare 2023, 11, 1118. [Google Scholar] [CrossRef]
- Tripathi, R.M.; Seth, P.; Awasthi, P.; Bhattacharya, A.; Bajpai, A.K.; Thahriani, A. Psychosomatic disorders affecting the oral cavity: A review article. The Pharma Innovation Journal. 2018, 7, 327–332. [Google Scholar]
- Dhimole, A.; Bhasin, N.; Pandya, D.; Dwivedi, N.; Nagarajappa, A.K. Psychosomatic Disorders Affecting the Mouth: A Critical Review. Journal of Advances in Medicine and Medical Research. 2016, 14, 1–9. [Google Scholar] [CrossRef]
- Shamim, T. The psychosomatic disorders pertaining to dental practice with revised working type classification. Korean J Pain. 2014, 27, 16–22. [Google Scholar] [CrossRef]
- Córdova, P.; Rubio, A.; Echeverría, P. Oral lichen planus: A look from diagnosis to treatment. J Oral Res. 2014, 3, 62–67. [Google Scholar] [CrossRef]
- Chiang, C.P.; Yu-Fong Chang, J.; Wang, Y.P.; Wu, Y.H.; Lu, S.Y.; Sun, A. Oral lichen planus—Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management. J Formos Med Assoc. 2018, 117, 756–765. [Google Scholar] [CrossRef]
- Nosratzehi, T. Oral Lichen Planus: An Overview of Potential Risk Factors, Biomarkers and Treatments. Asian Pac J Cancer Prev. 2018, 19, 1161–1167. [Google Scholar] [CrossRef] [PubMed]
- González-Moles, M.Á.; Warnakulasuriya, S.; González-Ruiz, I.; et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021, 27, 813–828. [Google Scholar] [CrossRef] [PubMed]
- El-Howati, A.; Thornhill, M.H.; Colley, H.E.; Murdoch, C. Immune mechanisms in oral lichen planus. Oral Dis. 2023, 29, 1400–1415. [Google Scholar] [CrossRef]
- Mutafchieva, M.Z.; Draganova-Filipova, M.N.; Zagorchev, P.I.; Tomov, G.T. Oral Lichen Planus—Known and Unknown: A Review. Folia Med (Plovdiv). 2018, 60, 528–535. [Google Scholar] [CrossRef]
- Parihar, A.; Sharma, S.; Bhattacharya, S.N.; Singh, U.R. A clinicopathological study of cutaneous lichen planus. J Dermatology & Dermatol Surg. 2015, 19, 21–26. [Google Scholar] [CrossRef]
- Tocut, S.M.; Mitran, M.I.; Mitran, C.I.; Tampa, M. Photodynamic therapy as a new therapeutic approach of oral lichen planus. J Mind Med Sci. 2019, 6, 64–71. [Google Scholar] [CrossRef]
- Panta, P.; Andhavarapu, A.; Patil, S.A. Holistic Intervention for Oral Lichen Planus. J Contemp Dent Pract. 2019, 20, 765–767. [Google Scholar] [CrossRef]
- Chaudhary, S. Psychosocial stressors in oral lichen planus. Aust Dent J. 2004, 49, 192–195. [Google Scholar] [CrossRef]
- Burkhart, N.W.; Burkes, E.J.; Burker, E.J. Meeting the educational needs of patients with oral lichen planus. Gen Dent. 1997, 45, 126–144. [Google Scholar]
- Rojo-Moreno, J.L.; Bagán, J.V.; Rojo-Moreno, J.; Donat, J.S.; et al. Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998, 86, 687–691. [Google Scholar] [CrossRef]
- Boch, K.; Langan, E.A.; Kridin, K.; et al. Lichen Planus. Front Med. 2021, 8, 737813. [Google Scholar] [CrossRef] [PubMed]
- Spirito, F.; Dioguardi, M.; Caponio, V.C.; Ambrosino, M.; Lo Muzio, E.; Lo Muzio, L. Oral lichen planus in children: A systematic review. Med Oral Patol Oral Cir Bucal. 2024, 29, e152. [Google Scholar] [CrossRef] [PubMed]
- Cox, T.; Woodhead, J.; Nelson, B.L. Reticular Oral Lichen Planus. Head Neck Pathol. 2020, 14, 192–194. [Google Scholar] [CrossRef]
- Keller, L.M.; Lombardi, T. Gingival lichen planus: A clinical and pathological study. J Stomatol Oral Maxillofac Surg. 2023, 124, 101354. [Google Scholar] [CrossRef] [PubMed]
- Didona, D.; Caposiena Caro, R.D.; Sequeira Santos, A.M.; Solimani, F.; Hertl, M. Therapeutic strategies for oral lichen planus: State of the art and new insights. Front Med. 2022, 9, 997190. [Google Scholar] [CrossRef]
- Shavit, E.; Hagen, K.; Shear, N. Oral lichen planus: A novel staging and algorithmic approach and all that is essential to know. F1000Res. 2020, 9, F1000. [Google Scholar] [CrossRef]
- Rotaru, D.; Chisnoiu, R.; Picos, A.M.; Picos, A.; Chisnoiu, A. Treatment trends in oral lichen planus and oral lichenoid lesions (Review). Exp Ther Med. 2020, 20, 198. [Google Scholar] [CrossRef]
- Gupta, S.; Jawanda, M.K. Oral Lichen Planus: An Update on Etiology, Pathogenesis, Clinical Presentation, Diagnosis and Management. Indian J Dermatol. 2015, 60, 222–229. [Google Scholar] [CrossRef]
- Sánchez-Bernal, J.; Conejero, C.; Conejero, R. Recurrent Aphthous Stomatitis. Aftosis oral recidivante. Actas Dermosifiliogr (Engl Ed). 2020, 111, 471–480. [Google Scholar] [CrossRef]
- Al-Hashimi, I.; Schifter, M.; Lockhart, P.B.; et al. Oral lichen planus and oral lichenoid lesions: Diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 103, S25.e1–S25.e12. [Google Scholar] [CrossRef]
- Gallo Cde, B.; Mimura, M.A.; Sugaya, N.N. Psychological stress and recurrent aphthous stomatitis. Clinics (Sao Paulo). 2009, 64, 645648. [Google Scholar] [CrossRef]
- Slebioda, Z.; Szponar, E.; Kowalska, A. Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: Literature review. Arch Immunol Ther Exp. 2014, 62, 205–215. [Google Scholar] [CrossRef] [PubMed]
- Byahatti, S.M. Incidence of Recurrent Apthous ulcers in a group of student population in Libya: A Questionnaire Study. Arch Cran OroFac Sc. 2013, 1, 26–30. [Google Scholar] [CrossRef]
- Edgar, N.R.; Saleh, D.; Miller, R.A. Recurrent Aphthous Stomatitis: A Review. J Clin Aesthet Dermatol. 2017, 10, 26–36. [Google Scholar]
- Manfredini, M.; Guida, S.; Giovani, M.; et al. Recurrent Aphthous Stomatitis: Treatment and Management. Dermatol Pract Concept. 2021, 11, e2021099. [Google Scholar] [CrossRef]
- Altenburg, A.; Zouboulis, C.C. Current concepts in the treatment of recurrent aphthous stomatitis. Skin Therapy Lett. 2008, 13, 1–4. [Google Scholar]
- Arida, A.; Fragiadaki, K.; Giavri, E.; et al. Anti-TNF agents for Behçet’s disease: Analysis of published data on 369 patients. Semin Arthritis Rheum. 2011, 41, 61–70. [Google Scholar] [CrossRef]
- Akerzoul, N.; Chbicheb, S. Low laser therapy as an effective treatment of recurrent aphtous ulcers: A clinical case reporting two locations. Pan Afr Med J. 2018, 30, 205. [Google Scholar] [CrossRef]
- Hooten, W.M. Literature review: Stress reactance in psoriatic patients. Jefferson J Psychiatry. 1994, 12, 51–57. [Google Scholar] [CrossRef]
- Polak, K.; Bergler-Czop, B.; Szczepanek, M.; Wojciechowska, K.; Frątczak, A.; Kiss, N. Psoriasis and Gut Microbiome-Current State of Art. Int J Mol Sci. 2021, 22, 4529. [Google Scholar] [CrossRef]
- Armstrong, A.W.; Read, C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020, 323, 1945–1960. [Google Scholar] [CrossRef] [PubMed]
- Sathyanarayana Rao, T.S.; Basavaraj, K.H.; Das, K. Psychosomatic paradigms in psoriasis: Psoriasis, stress and mental health. Indian J Psychiatry. 2013, 55, 313–315. [Google Scholar] [CrossRef]
- Woźniak, E.; Owczarczyk-Saczonek, A.; Placek, W. Psychological Stress, Mast Cells, and Psoriasis-Is There Any Relationship? Int J Mol Sci. 2021, 22, 13252. [Google Scholar] [CrossRef] [PubMed]
- Sarbu, M.I.; Tampa, M.; Sarbu, A.E.; Georgescu, S.R. Sexual Dysfunctions in Psoriatic Patients. J Mind Med Sci. 2014, 1, 19–27. [Google Scholar] [CrossRef]
- Hepat, A.; Chakole, S.; Rannaware, A. Psychological Well-Being of Adult Psoriasis Patients: A Narrative Review. Cureus. 2023, 15, e37702. [Google Scholar] [CrossRef]
- Khan, S.; Zaheer, S.; Gupta, N. Oral psoriasis: A diagnostic dilemma. Eur J Gen Dent. 2013, 2, 67–71. [Google Scholar] [CrossRef]
- Sobecka-Frankiewicz, M.; Rudnicka, J.; Iwanicka-Grzegorek, E.; Mielczarek, A. Oral changes in patients with psoriasis. Int J Dermatol. 2023, 62, 604–610. [Google Scholar] [CrossRef]
- Picciani, B.L.; Souza, T.T.; Santos Vde, C.; et al. Geographic tongue and fissured tongue in 348 patients with psoriasis: Correlation with disease severity. ScientificWorldJournal. 2015, 2015, 564326. [Google Scholar] [CrossRef]
- Germi, L.; De Giorgi, V.; Bergamo, F.; et al. Psoriasis and oral lesions: Multicentric study of Oral Mucosa Diseases Italian Group (GIPMO). Dermatol Online J. 2012, 18, 11. [Google Scholar] [CrossRef]
- Picciani, B.L.; Domingos, T.A.; Teixeira-Souza, T.; Dos Santos, V.; et al. Geographic tongue and psoriasis: Clinical, histopathological, immunohistochemical and genetic correlation—A literature review. An Bras Dermatol. 2016, 91, 410–421. [Google Scholar] [CrossRef]
- Picciani, B.; Santos, V.C.; Teixeira-Souza, T.; et al. Investigation of the clinical features of geographic tongue: Unveiling its relationship with oral psoriasis. Int J Dermatol. 2017, 56, 421–427. [Google Scholar] [CrossRef] [PubMed]
- Tokuyama, M.; Mabuchi, T. New Treatment Addressing the Pathogenesis of Psoriasis. Int J Mol Sci. 2020, 21, 7488. [Google Scholar] [CrossRef] [PubMed]
- Bakshi, H.; Nagpal, M.; Singh, M.; Dhingra, G.A.; Aggarwal, G. Treatment of Psoriasis: A Comprehensive Review of Entire Therapies. Curr Drug Saf. 2020, 15, 82–104. [Google Scholar] [CrossRef] [PubMed]
- Lebwohl, M. Psoriasis. Ann Intern Med. 2018, 168, ITC49–ITC64. [Google Scholar] [CrossRef]
- Xu, H.H.; Werth, V.P.; Parisi, E.; Sollecito, T.P. Mucous membrane pemphigoid. Dent Clin North Am. 2013, 57, 611–630. [Google Scholar] [CrossRef]
- McFadden, J.R.; Chaudhari, A.S.; Birenbaum, D.; Margesson, L.; Gonzalez, J.; Sriharan, A. An Underrecognized Histologic Clue to the Diagnosis of Mucous Membrane Pemphigoid: A Case Report and Review of Diagnostic Guidelines. Dermatopathology 2023, 10, 63–69. [Google Scholar] [CrossRef]
- Du, G.; Patzelt, S.; van Beek, N.; Schmidt, E. Mucous membrane pemphigoid. Autoimmun Rev. 2022, 21, 103036. [Google Scholar] [CrossRef]
- Finn, D.J.; Graham, C.; Holt, D.J.; Kelly, R.; Rajlawat, B.P.; Yesudian, P.D. Management of mucous membrane pemphigoid in a joint oral medicine-dermatology clinic. Clin Exp Dermatol. 2020, 45, 685690. [Google Scholar] [CrossRef]
- Rashid, H.; Lamberts, A.; Borradori, L.; et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology Part I. J Eur Acad Dermatol Venereol. 2021, 35, 1750–1764. [Google Scholar] [CrossRef]
- Buajeeb, W.; Pimolbutr, K.; Panpradit, N.; Okuma, N. Oral mucous membrane pemphigoid in a group of Thai patients-A 15-year retrospective study. J Dent Sci. 2022, 17, 1009–1017. [Google Scholar] [CrossRef]
- Saccucci, M.; Di Carlo, G.; Bossù, M.; Giovarruscio, F.; Salucci, A.; Polimeni, A. Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management. J Immunol Res. 2018, 2018, 6061825. [Google Scholar] [CrossRef]
- Cizenski, J.D.; Michel, P.; Watson, I.T.; et al. Spectrum of orocutaneous disease associations: Immune-mediated conditions. J Am Acad Dermatol. 2017, 77, 795–806. [Google Scholar] [CrossRef] [PubMed]
- Maity, S.; Banerjee, I.; Sinha, R.; Jha, H.; Ghosh, P.; Mustafi, S. Nikolsky’s sign: A pathognomic boon. J Family Med Prim Care. 2020, 9, 526–530. [Google Scholar] [CrossRef] [PubMed]
- Petruzzi, M. Mucous membrane pemphigoid affecting the oral cavity: Short review on etiopathogenesis, diagnosis and treatment. Immunopharmacol Immunotoxicol. 2012, 34, 363–367. [Google Scholar] [CrossRef] [PubMed]
- Scully, C.; Lo Muzio, L. Oral mucosal diseases: Mucous membrane pemphigoid. Br J Oral Maxillofac Surg. 2008, 46, 358–366. [Google Scholar] [CrossRef]
- Buonavoglia, A.; Leone, P.; Dammacco, R.; et al. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy. Autoimmun Rev. 2019, 18, 349–358. [Google Scholar] [CrossRef]
- Malik, A.M.; Tupchong, S.; Huang, S.; Are, A.; Hsu, S.; Motaparthi, K. An Updated Review of Pemphigus Diseases. Medicina 2021, 57, 1080. [Google Scholar] [CrossRef]
- Costan, V.V.; Popa, C.; Hâncu, M.F.; Porumb-Andrese, E.; Toader, M.P. Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review). Exp Ther Med. 2021, 22, 1335. [Google Scholar] [CrossRef]
- Baum, S.; Astman, N.; Berco, E.; et al. Epidemiological data of 290 pemphigus vulgaris patients: A 29-year retrospective study. Eur J Dermatol. 2016, 26, 382–387. [Google Scholar] [CrossRef]
- Giannetti, L.; Generali, L.; Bertoldi, C. Oral pemphigus. G Ital Dermatol Venereol. 2018, 153, 383–388. [Google Scholar] [CrossRef]
- Schmidt, E.; Kasperkiewicz, M.; Joly, P. Pemphigus. Lancet. 2019, 394, 882–894. [Google Scholar] [CrossRef] [PubMed]
- Tavakolpour, S. Pemphigus trigger factors: Special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res. 2018, 310, 95–106. [Google Scholar] [CrossRef] [PubMed]
- Caccavale, S.; Lo Schiavo, A. Psychiatric morbidity and pemphigus: A review of theories and literature on pathogenesis. G Ital Dermatol Venereol. 2016, 151, 198–202. [Google Scholar] [PubMed]
- Bascones-Martínez, A.; García-García, V.; Meurman, J.H.; RequenaCaballero, L. Immune-mediated diseases: What can be found in the oral cavity? Int J Dermatol. 2015, 54, 258–270. [Google Scholar] [CrossRef]
- Trayes, K.P.; Love, G.; Studdiford, J.S. Erythema Multiforme: Recognition and Management. Am Fam Physician. 2019, 100, 8288. [Google Scholar]
- Samim, F.; Auluck, A.; Zed, C.; Williams, P.M. Erythema multiforme: A review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013, 57, 583–596. [Google Scholar] [CrossRef]
- Soares, A.; Sokumbi, O. Recent Updates in the Treatment of Erythema Multiforme. Medicina (Kaunas). 2021, 57, 921. [Google Scholar] [CrossRef]
- Lefaucheur, J.P.; Valeyrie-Allanore, L.; Ng Wing Tin, S.; et al. Chronic pain: A long-term sequela of epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis)—Prevalence, clinical characteristics and risk factors. J Eur Acad Dermatol Venereol. 2021, 35, 188–194. [Google Scholar] [CrossRef]
- Garma, M.; Sioud, S.; Omami, M.; Slim, A.; Abdellatif, C.; Selmi, J. Oral erythema multiforme related to bronchodilators intake: A report of a case. Clin Case Rep. 2022, 10, e6331. [Google Scholar] [CrossRef]
- Ayangco, L.; Rogers, R.S. , 3rd. Oral manifestations of erythema multiforme. Dermatol Clin. 2003, 21, 195–205. [Google Scholar] [CrossRef]
Minor Ulcers (MiRAS) | Major ulcers (MaRAS) | Herpetiformis Ulcers (HU) | |
---|---|---|---|
Prevalence | 75–85% | 10–15% | 1–10% |
Clinical signs | Painful, round or oval ulcers with shallow necrotic centers, raised edges, usually with a gray white pseudomembrane and an erythematous halo. | ||
Size | <10 mm | >10 mm | 2–3 mm |
Localization | Unattached mucosaZZBB(labial and buccal mucosa, the mouth floor) | Unattached mucosa ZZBB(lips, soft palate, and fauces) | Attached mucosa ZZBB(gingiva) |
Duration | 10–14 days | up to 6 weeks | <1 month (7–10 days) |
Scars | Yes | Sometimes | No |
© 2024 by the author. 2024 Nadya T. Avramova, Boyko K. Bonev
Share and Cite
Avramova, N.T.; Bonev, B.K. The Role of Psychogenic Factors in the Etiopathogenesis of Autoimmune Disorders in the Oral Cavity. J. Mind Med. Sci. 2024, 11, 10-16. https://doi.org/10.22543/2392-7674.1450
Avramova NT, Bonev BK. The Role of Psychogenic Factors in the Etiopathogenesis of Autoimmune Disorders in the Oral Cavity. Journal of Mind and Medical Sciences. 2024; 11(1):10-16. https://doi.org/10.22543/2392-7674.1450
Chicago/Turabian StyleAvramova, Nadya T., and Boyko K. Bonev. 2024. "The Role of Psychogenic Factors in the Etiopathogenesis of Autoimmune Disorders in the Oral Cavity" Journal of Mind and Medical Sciences 11, no. 1: 10-16. https://doi.org/10.22543/2392-7674.1450
APA StyleAvramova, N. T., & Bonev, B. K. (2024). The Role of Psychogenic Factors in the Etiopathogenesis of Autoimmune Disorders in the Oral Cavity. Journal of Mind and Medical Sciences, 11(1), 10-16. https://doi.org/10.22543/2392-7674.1450